1. Parties
This Partner Program Agreement ("Agreement") is between TelePeptide LLC, a New Jersey limited liability company ("TelePeptide," "we," "us," or "our"), and the individual, healthcare practice, or business entity identified in the partner application ("Partner" or "you"). By submitting a partner application at telepeptide.org/partner or by referring any patient to TelePeptide through your unique referral link or Partner Code, you agree to these terms in full. The Partner Program is a single unified program open to both licensed healthcare providers and content creators / general marketers: the commission structure is identical for both audiences.
2. Eligibility
To participate as a TelePeptide partner you must be: (a) at least 18 years of age; (b) operating in a lawful capacity in your jurisdiction; (c) able to receive US-affiliate-style payments in your name or your business's name; (d) not currently sanctioned, excluded, or convicted in a way that would prohibit receipt of marketing fees from a US healthcare company. If you are a US-licensed healthcare provider participating as a partner: you must hold an active and unrestricted license (MD, DO, NP, PA, DC, ND, RD, LMHC, or equivalent) and must not be subject to any state medical board investigation, DEA action, or OIG exclusion. We may verify your license through publicly available state board databases. If you are a content creator: you must be operating a website, newsletter, social-media channel, podcast, YouTube channel, or other public-facing content platform (or planning to launch one within 90 days of approval). We do not require minimum audience size. We may decline any application without explanation.
3. The Partner Program
Once approved, TelePeptide will issue you a unique Partner Code and a personalized referral link to our enrollment store. You may share these with patients in a clinical setting, clients, audience, readers, podcast listeners, social-media followers, or in any other lawful channel. Enrollment and checkout take place on the TelePep store on the Bask Health platform; clinical evaluation and prescribing are performed by independent licensed clinicians with Lone Star Virtual Health PLLC through that platform; and prescriptions are filled and shipped by licensed US pharmacies, with compounded medications prepared by licensed US compounding pharmacies. You handle the recommendation and the audience/patient relationship. You are not engaged as our employee, agent, joint venturer, or franchisee; you are an independent contractor.
4. Commission: How We Calculate Your Payment
You earn fifteen percent (15%) of the Net Subscription Revenue we collect from each Active Referred Patient, every month they remain active, for the first twelve (12) months of their subscription, SUBJECT TO A FIFTY US DOLLAR ($50) PER-PATIENT-PER-MONTH CAP. The cap applies independently each month: if 15% of that month's Net Subscription Revenue (Section 5) exceeds $50, you receive $50 for that month; otherwise you receive the full 15%. For a monthly-billed plan priced at or below the cap threshold ($333/mo), the cap does not reduce your commission; for a plan priced above it, the cap limits each month's commission to $50. After month 12, recurring commission ends; the underlying patient subscription continues with TelePeptide. There is no cap on the number of patients you may refer, no quota or minimum, and no exclusivity requirement.
5. Calculation Details
"Net Subscription Revenue" = the monthly subscription fee actually charged to and paid by the referred patient, MINUS any refunds, chargebacks, processing-fee reversals, partial credits, or promo-code discounts the patient applied. The 12-month recurring window begins the FIRST MONTH the patient is billed, not the day they signed up, so if a patient signs up December 28 and the first invoice clears January 2, recurring runs January through December of the following year. The $50/mo cap is applied AFTER the 15% calculation and AFTER any Net adjustments: if 15% × Net for a given month is $40, you receive $40 (under cap); if it is $60, you receive $50 (capped). The cap is per-patient-per-month and does not aggregate across patients; you do not lose commission on patient #2 just because patient #1 hit the cap that month. "Active Referred Patient" = a patient who (a) is attributed to your partner account under Section 8 (through your unique referral link or Partner Code as recorded by the enrollment store on the patient's first paid order, or by our manual confirmation under that Section), AND (b) has a paid invoice in the current billing month that has not been refunded or charged back. Refunds, chargebacks, or patient-initiated subscription credits reverse the corresponding commission in your next monthly statement. PREPAID PLANS: for a plan that covers several months in one charge (a 3-, 6- or 12-month plan), we spread that charge's Net Subscription Revenue evenly over the months it covers and apply the 15% rate and the $50 per-month cap to each of those months that falls inside the 12-month window. Each covered month counts as a paid month for the Active Referred Patient test above, and a refund or chargeback of that charge reverses the commission for every month it covered.
6. Payout Schedule and Method
We close each commission month on the last calendar day. Earned commissions are paid out on the 15th of the following month (e.g. January commissions paid February 15). Minimum payout threshold is twenty-five US dollars ($25); balances below the threshold roll forward to the next month. Each month we email you a statement of the orders attributed to you and the commission earned, without patient names or contact details. We send each payout ourselves, by ACH (US partners) or wire transfer (partners outside the US), or by PayPal on request; before your first payout we will ask for your payment details and your tax form (Form W-9 for US partners, or the Form W-8BEN or W-8BEN-E required by Section 7 for others). We pay our own bank's fee to send a payout; any fee your bank, an intermediary bank, or PayPal charges to receive it is yours. You are responsible for accurate banking and tax information; we are not liable for payments delayed or misrouted due to incorrect information you provide.
7. Tax Reporting
You are an independent contractor responsible for all federal, state, and local taxes on commissions earned. We will report commissions to tax authorities, issue information returns (such as IRS Form 1099-NEC), and withhold tax from payments when and as required by applicable law. Before your first payout, US partners must provide IRS Form W-9 and non-US partners IRS Form W-8BEN (individual) or W-8BEN-E (entity); without a valid form, we may be required by law to withhold tax from your payments. You agree to indemnify TelePeptide against any tax liability that arises from your failure to report or pay tax on commissions you receive.
8. Attribution
A patient is attributed to your partner account when the enrollment store records your unique referral link or your Partner Code on the patient's first paid order. Your referral link opens a product page on the enrollment store with your Partner Code, which the store applies to the order. If the store records more than one partner's link or code on that order, the Partner Code applied to the order controls, and if no Partner Code was applied, the referral link the store recorded controls. Once attributed, the patient stays attributed to that partner for their 12-month commission window, even if they later return through another channel or another partner's link or code. If no partner's link or Partner Code is recorded on that order, no commission is paid even if you previously mentioned TelePeptide to the patient, unless we confirm the attribution manually: the patient may ask us once, by email to ahmed@telepeptide.org within 14 days after that order, to attribute it to a named partner (intended for cases where the referral was not recorded or the patient forgot to use the link). Manual confirmation is not available for an order on which the store recorded another partner's link or code.
9. Promotional Conduct: What You May and May Not Do
You MAY: recommend TelePeptide to patients, clients, or audience members in any lawful channel: clinical settings, newsletters, blog posts, social posts, podcasts, YouTube videos, paid Meta/TikTok/Instagram ads (subject to platform health policies AND the prior-written-approval requirement at the end of this Section); use brand assets (logo, screenshots, copy snippets, lifestyle imagery) that we provide on request, following any brand guidelines we send with them; quote our published pricing and program descriptions verbatim. You MAY NOT: (a) make any clinical claims, weight-loss guarantees, or outcome promises that TelePeptide has not published; (b) describe compounded medications as "FDA-approved"; they are not; (c) imply TelePeptide is a substitute for in-person care when in-person care is clinically indicated; (d) bid on TelePeptide-branded keywords ("telepeptide", "tele peptide", or close variants) in paid search ("Brand Bidding"); (e) use spam, mass unsolicited email, automated bots, cookie-stuffing, browser hijacking, popup-bait, or any other CAN-SPAM/TCPA-violating outreach; (f) misrepresent the TelePeptide brand, our pricing, or your relationship with us; (g) operate fake "independent review" sites that funnel all traffic to TelePeptide while presenting themselves as neutral; (h) sell or transfer your Partner Code or referral link to a third party; (i) target audiences under 18; (j) market, list, display, or co-locate TelePeptide's brand, programs, pricing, or referral links alongside (or on the same page, storefront, or section as) "research use only" (RUO), "not for human consumption," or other research-grade / non-clinical peptides, chemicals, or supplements. TelePeptide is a telehealth platform whose products are clinician-prescribed and dispensed by licensed pharmacies (compounded medications by licensed compounding pharmacies), and they must be kept clearly and visibly separate from any research-use inventory; (k) use third-party pharmaceutical manufacturers' brand names or trademarks to describe, advertise, or imply equivalence with TelePeptide's compounded offerings (describe them by active ingredient only, e.g. "compounded tirzepatide"); (l) name a brand-name medication sold through TelePeptide other than as the name of that product together with its maker's name, state or imply that TelePeptide or you are affiliated with, sponsored by or endorsed by its maker, compare it with or present it as interchangeable with a compounded medication, or mention it without the risk information we provide for that product. PAID ADVERTISING: PRIOR WRITTEN APPROVAL REQUIRED: before running any paid advertisement that references TelePeptide (paid search, paid social, display, sponsored newsletter placements, or paid influencer boosts), you must submit the final ad creative, copy, landing destination, and audience targeting to legal@telepeptide.org, with a copy to ahmed@telepeptide.org, and receive written approval. You must pause or remove any ad we flag, and re-submit for approval after any material change. Our review is a brand- and compliance-consistency screen only: approval does NOT constitute legal advice, does not certify your ad's compliance with any law or platform policy, and does not transfer to TelePeptide any responsibility for your advertising; you remain solely responsible for the legal compliance of every ad you run. Effective date of the July 20, 2026 additions (clause (k) and this paid-advertising approval requirement): immediately for partners approved on or after July 20, 2026; for partners approved before that date, fifteen (15) days after email notice, per Section 18. Clause (l), added November 12, 2026, takes effect immediately for partners approved on or after November 12, 2026 and, for partners approved before that date, fifteen (15) days after email notice, per Section 18. Violation of these rules is grounds for immediate suspension and forfeiture of unpaid commissions.
10. FTC Disclosure: Required for Public Promotion
You agree to comply with the US Federal Trade Commission's Endorsement Guides (16 CFR Part 255) on every piece of public-facing partner content. In practice, this means a clear and conspicuous disclosure of your material connection to TelePeptide on any post, video, story, email, or other content that includes your referral link or Partner Code. Acceptable disclosure formats include: "#ad", "#affiliate", "#partner", or plain-English statements such as "TelePeptide is a partner; I earn a commission if you sign up through my link." The disclosure must appear above the fold (visible without scrolling/expanding "more" sections), in the same language as the content, and not buried in a wall of tags. Video creators must include both visible on-screen text and spoken disclosure in the first 30 seconds. Newsletter authors must include the disclosure in the body of the email, not just the footer. This Section applies primarily to content-creator partners; licensed healthcare providers should additionally consult Section 11 regarding clinical-disclosure obligations.
11. Clinical Compliance: Anti-Kickback, Stark, and Provider Conduct
If you are a licensed healthcare provider participating as a partner, you acknowledge that the Federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b) and the Stark Law (42 U.S.C. § 1395nn), where applicable, prohibit payment for patient referrals that involve federal healthcare programs (Medicare, Medicaid, TRICARE). TelePeptide is a direct-pay cash-pay service and DOES NOT accept federal healthcare program payments. The 15% commission is paid only on cash-pay subscriptions. As a provider partner, you are responsible for (a) determining whether your participation is permitted under your state's fee-splitting and patient-brokering laws; (b) disclosing your financial relationship with TelePeptide to your patients before recommending our programs, in a manner that satisfies your state's fiduciary and informed-consent requirements; (c) ensuring that your recommendation is based on the patient's independent clinical interest and not solely on the commission opportunity; (d) NOT prescribing or recommending TelePeptide programs to your federal-healthcare-program patients in a manner that could be characterized as a kickback for clinical referral. We strongly encourage provider partners to consult their own healthcare-compliance attorney before joining.
12. Medical Content Standards (Non-Provider Partners)
If you are NOT a licensed healthcare provider, you acknowledge that you are NOT acting in a clinical capacity for TelePeptide audiences. Specifically: (a) you must not provide individualized medical advice, dosing recommendations, eligibility opinions, or contraindication assessments; (b) you must direct audience medical questions to the independent licensed clinicians who review TelePep intakes (e.g. "ask the reviewing clinician whether this is right for you"); (c) you must include in any content that mentions a medication a disclaimer that each medication you mention is a prescription medication subject to clinician approval and carries side effects; (d) you must not promote off-label uses TelePeptide has not formally endorsed. Suggested boilerplate disclaimer (you may copy/paste verbatim): "Compounded medications discussed here are prescribed by independent licensed US clinicians and dispensed by licensed US compounding pharmacies. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Not everyone is prescribed. Side effects exist. Always consult a clinician; your payment method is authorized for the amount shown at checkout, and if a clinician does not prescribe, the hold is released and you are not charged." Suggested boilerplate for a brand-name medication sold through TelePeptide (fill in the brackets): "[Brand name] is an FDA-approved prescription medication made by [maker]. TelePeptide and I are not affiliated with [maker]. It is prescribed by independent licensed US clinicians only if appropriate and dispensed by licensed US pharmacies. Side effects exist; see the risk information TelePeptide provides. Always consult a clinician."
13. Confidentiality and HIPAA
You will not have access to TelePeptide patient Protected Health Information (PHI) by virtue of being a partner. Your monthly statement and partner dashboard list your attributed orders only by anonymous reference, with dates, amounts, and commission earned, and never show patient names or contact details. If you are a healthcare provider and you provide direct patient-facing care to a person you have also referred to TelePeptide, your relationship with that patient remains governed by your own clinical practice's HIPAA obligations: TelePeptide is not your Business Associate for that purpose. You agree not to use TelePeptide partner data, conversion statistics, or pricing tables to compete with TelePeptide or to enable a third party to do so.
14. Brand and Intellectual Property
TelePeptide grants you a limited, revocable, non-exclusive, non-transferable license to use our trademarks, logo, screenshots, and copy snippets solely for the purpose of promoting TelePeptide through your referral link or Partner Code. You agree to use only assets we provide to you on request, without distortion or modification, and to follow any brand guidelines we send with them; you may not modify program names or pricing. You may not register a domain name, social handle, app name, or business name that incorporates "TelePeptide", "Tele Peptide", or any close variant. All goodwill from your use of the brand inures to TelePeptide.
15. Termination and Trailing Commissions
Either party may terminate this Agreement at any time, for any reason, on thirty (30) days written notice via email to the other party (ahmed@telepeptide.org for notices to TelePeptide). On termination by either party in good standing, you will continue to earn trailing commissions on Active Referred Patients you brought in prior to termination, for the remainder of each patient's original 12-month recurring window OR six (6) additional months from the termination date, whichever ends sooner. Trailing commissions follow all the same calculation rules in Sections 4 and 5 (including the $50/mo per-patient cap and refund clawbacks). TelePeptide may terminate this Agreement immediately, and you forfeit any unpaid commissions, if you breach Section 9 (Promotional Conduct), Section 10 (FTC Disclosure), Section 11 (Clinical Compliance), Section 12 (Medical Content), or any applicable law.
16. Disclaimers and Limitation of Liability
The partner program, dashboard, and referral-link infrastructure are provided "as is" without warranties of any kind. We make no guarantee of any minimum number of referrals, orders, or commission amount. We may modify program mechanics, commission rates, attribution rules, the cap value, or the underlying patient programs at any time with at least fifteen (15) days notice via email. TelePeptide's aggregate liability to you for any claim is limited to the total commissions paid or owed to you in the six (6) months preceding the claim. Neither party will be liable for indirect, incidental, special, consequential, or punitive damages, regardless of legal theory. Nothing in this Section limits either party's liability for fraud, willful misconduct, or breach of confidentiality obligations.
17. Governing Law and Disputes
This Agreement is governed by the laws of the State of New Jersey without regard to conflict-of-laws principles. Any dispute arising from or relating to this Agreement that the parties cannot resolve in good faith within thirty (30) days will be resolved by binding individual arbitration administered by JAMS under its Streamlined Arbitration Rules, conducted in Bergen County, New Jersey, with the prevailing party entitled to recover reasonable attorneys' fees. You waive any right to a jury trial and to participate in a class action or class-wide arbitration. Either party may seek injunctive or equitable relief in a court of competent jurisdiction to protect intellectual property, enforce confidentiality, or prevent immediate harm.
18. Entire Agreement, Amendments, Severability
This Agreement, together with the TelePeptide Terms & Conditions at /terms and Privacy Policy at /privacy-policy, constitutes the entire agreement between you and TelePeptide concerning the partner program. Material amendments will be communicated by email at least fifteen (15) days in advance and posted at /partner/terms. If any provision is found unenforceable, the remaining provisions remain in full force. No oral or informal statement modifies this Agreement. The November 16, 2026 revisions to Sections 4, 5, 6, 7, 8, 9, 12, 13, 14, 15 and 16 apply immediately to partners approved on or after November 16, 2026 and, for partners approved before that date, fifteen (15) days after email notice.
19. Contact
Partner program inquiries and commission questions: ahmed@telepeptide.org. Compliance / disclosure / legal questions: legal@telepeptide.org, with a copy to ahmed@telepeptide.org. Mailing address for formal notices: TelePeptide LLC, 2077 Center Ave, Fort Lee, NJ 07024.